Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 46, 2011, Pages

  MacLauchlan, Susan ^a   Yu, Jun ^a   Parrish, Marcus ^a   Asoulin, Tara A ^a   Schleicher, Michael ^a   Krady, Marie M ^a   Zeng, Jianmin ^a   Huang, Paul L ^b   Sessa, William C ^a   Kyriakides, Themis R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Akt; Extracellular matrix; Matrix metalloproteinases; Wound healing

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; THROMBOSPONDIN 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE ACTIVITY; GENE INACTIVATION; GENE REPRESSION; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; LEG ISCHEMIA; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN INJURY; WILD TYPE; WOUND HEALING;

ANIMALS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HUMANS; ISCHEMIA; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION; SKIN; THROMBOSPONDINS;

MUS;

EID: 81755185894     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1104357108     Document Type: Article

References (55)

1. Rudic RD, et al. (1998) Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101:731-736. (Pubitemid 28096068)
2. Lee PC, et al. (1999) Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 277:H1600-H1608. (Pubitemid 29522694)
3. Yu J, et al. (2005) Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 102:10999-11004. (Pubitemid 41105982)
4. Schaffer MR, Tantry U, Gross SS, Wasserburg HL, Barbul A (1996) Nitric oxide regulates wound healing. J Surg Res 63:237-240. (Pubitemid 26197729)
5. Zhu H, Wei X, Bian K, Murad F (2008) Effects of nitric oxide on skin burn wound healing. J Burn Care Res 29:804-814.
6. Schäffer MR, et al. (1997) Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 158:2375-2381. (Pubitemid 127470024)
7. Witte MB, Thornton FJ, Efron DT, Barbul A (2000) Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 4:572-582. (Pubitemid 32053268)
8. Murohara T, et al. (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567-2578. (Pubitemid 28270451)
9. Kuhlencordt PJ, et al. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104:448-454. (Pubitemid 32678276)
10. Bornstein P (2009) Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 3:189-200.
11. Yang Z, Kyriakides TR, Bornstein P (2000) Matricellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell 11:3353-3364.
12. Hahn-Dantona E, Ruiz JF, Bornstein P, Strickland DK (2001) The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J Biol Chem 276:15498-15503.
13. Agah A, Kyriakides TR, Lawler J, Bornstein P (2002) The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 161:831-839. (Pubitemid 34988370)
14. Kyriakides TR, Maclauchlan S (2009) The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal 3:215-225.
15. Kyriakides TR, et al. (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419-430. (Pubitemid 28078405)
16. Kyriakides TR, Tam JW, Bornstein P (1999) Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 113:782-787.
17. Krady MM, et al. (2008) Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am J Pathol 173:879-891.
18. Kyriakides TR, Leach KJ, Hoffman AS, Ratner BD, Bornstein P (1999) Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc Natl Acad Sci USA 96:4449-4454. (Pubitemid 29190356)
19. Kyriakides TR, Zhu YH, Yang Z, Huynh G, Bornstein P (2001) Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol 159:1255-1262. (Pubitemid 32947955)
20. Agah A, Kyriakides TR, Letrondo N, Björkblom B, Bornstein P (2004) Thrombospondin 2 levels are increased in aged mice: Consequences for cutaneous wound healing and angiogenesis. Matrix Biol 22:539-547. (Pubitemid 38283777)
21. Maclauchlan S, et al. (2009) Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF. J Histochem Cytochem 57:301-313.
22. Isenberg JS, et al. (2006) CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281:26069-26080. (Pubitemid 44401813)
23. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD (2009) Regulation of nitric oxide signalling by thrombospondin 1: Implications for anti-angiogenic therapies. Nat Rev Cancer 9:182-194.
24. Bauer EM, et al. (2010) Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res 88:471-481.
25. Tang Y, et al. (2009) CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood 113:744-754.
26. Lopes N, et al. (2003) Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling. Mol Cell Biol 23:5401-5408. (Pubitemid 36950894)
27. Chen J, et al. (2005) Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med 11:1188-1196. (Pubitemid 43093666)
28. Somanath PR, Chen J, Byzova TV (2008) Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis 11:277-288.
29. Tian W, Sawyer A, Kocaoglu FB, Kyriakides TR (2011) Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier. Am J Pathol 179:860-868.
30. Krady M, et al. (2008) Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am J Pathol 173:879-891.
31. Keefer LK, Nims RW, Davies KM, Wink DA (1996) "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms. Methods Enzymol 268:281-293. (Pubitemid 26286370)
32. Borutaite V, Brown GC (2003) Nitric oxide induces apoptosis via hydrogen peroxide, but necrosis via energy and thiol depletion. Free Radic Biol Med 35:1457-1468. (Pubitemid 37452471)
33. Ackah E, et al. (2005) Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 115:2119-2127. (Pubitemid 41134153)
34. Schleicher M, et al. (2009) The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2:ra41.
35. Kyriakides TR, Maclauchlan S (2009) The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal 3:215-225.
36. Schroen B, et al. (2004) Thrombospondin-2 is essential for myocardial matrix integrity: Increased expression identifies failure-prone cardiac hypertrophy. Circ Res 95:515-522. (Pubitemid 39180932)
37. Matsunaga T, et al. (2002) Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105:2185-2191. (Pubitemid 34517163)
38. Frisbee JC, Samora JB, Basile DP (2007) Angiostatin does not contribute to skeletal muscle microvascular rarefaction with low nitric oxide bioavailability. Microcirculation 14:145-153. (Pubitemid 46951117)
39. Deininger MH, et al. (2003) Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J 17:1267-1276. (Pubitemid 36775773)
40. Wani J, Carl M, Henger A, Nelson PJ, Rupprecht H (2007) Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells. Biol Chem 388:497-506. (Pubitemid 46800261)
41. Ridnour LA, et al. (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 102:13147-13152. (Pubitemid 41324993)
42. Shingu T, Bornstein P (1993) Characterization of the mouse thrombospondin 2 gene. Genomics 16:78-84. (Pubitemid 23123794)
43. Tang Y, et al. (2009) CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress. Am J Physiol Cell Physiol 298(3):C665-C678.
44. Trachtman H, Futterweit S, Singhal P (1995) Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207:120-125.
45. Hohenstein B, Daniel C, Wittmann S, Hugo C (2008) PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis. Nephrol Dial Transplant 23:3427-3436.
46. Dooley A, et al. (2007) Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts. Free Radic Biol Med 43:253-264. (Pubitemid 46977167)
47. Myers PR, Tanner MA (1998) Vascular endothelial cell regulation of extracellular matrix collagen: Role of nitric oxide. Arterioscler Thromb Vasc Biol 18:717-722. (Pubitemid 28267650)
48. Kolpakov V, Gordon D, Kulik TJ (1995) Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 76:305-309.
49. Ridnour LA, et al. (2007) Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad Sci USA 104:16898-16903. (Pubitemid 350210962)
50. Zaragoza C, Balbín M, López-Otín C, Lamas S (2002) Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium. Kidney Int 61:804-808. (Pubitemid 34175443)
51. Jurasz P, et al. (2001) Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide. Cancer Res 61:376-382.
52. Shiojima I, Walsh K (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90:1243-1250. (Pubitemid 34787405)
53. Kyriakides TR, Zhu YH, Yang Z, Bornstein P (1998) The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 46:1007-1015. (Pubitemid 28402481)
54. Tian W, Kyriakides TR (2009) Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier. Matrix Biol 28:148-159.
55. Kuhlencordt PJ, et al. (2004) Role of endothelial nitric oxide synthase in endothelial activation: Insights from eNOS knockout endothelial cells. Am J Physiol Cell Physiol 286:C1195-C1202. (Pubitemid 38506935)